Selonsertib (GS-4997), an orally bioavailable, selective apoptosis signal-regulating kinase 1 (ASK1) inhibitor with a pIC50 of 8.3, has been evaluated as an experimental treatment for diabetic nephropathy and kidney fibrosis.
Molecular Weight:
445.49
Purity:
99.05
CAS Number:
[1448428-04-3]
Formula:
C24H24FN7O
Target:
Apoptosis,MAP3K
Application Notes:
Reference compound
* VAT and and shipping costs not included. Errors and price changes excepted